ProCE Banner Activity

Integrating MMRd/MSI Testing for Solid Tumors

Slideset Download
In this downloadable slideset, John L. Marshall, MD, discusses the current data on using MMRd/MSI status to select patients for treatment with immune checkpoint inhibitors across all solid tumors.

Released: May 31, 2019

Expiration: May 29, 2020

No longer available for credit.

Share

Faculty

John L. Marshall

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Array BioPharma

Bayer Healthcare Pharma

Blueprint Medicines

Celgene

Foundation Medicine

Genentech TEXT Only

Loxo Oncology

Merck Oncology

Puma Biotechnology, Inc.

Program Director Disclosure

Program Director

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC